Danone CEO Antoine de Saint-Affrique said the company has no interest in purchasing Reckitt Benckiser's Mead Johnson infant-formula unit [1].
The denial comes amid market speculation regarding the consolidation of the global baby food and formula sector. A potential acquisition of Mead Johnson would have significantly altered Danone's footprint in the specialized nutrition market, particularly in the U.S.
Saint-Affrique said that Danone is not pursuing the acquisition [1]. His comments address a period of uncertainty where various reports suggested the company might be interested in the unit [1].
This public dismissal follows conflicting reports about the company's intentions. While the CEO has denied the move, other reports suggested Danone may have resurrected interest in the infant-formula business [2]. The discrepancy highlights the volatility of merger and acquisition rumors in the consumer goods industry, where official corporate stances often clash with market intelligence.
Danone has not provided further details on its long-term strategy for the infant-formula segment beyond this denial. The company continues to navigate a competitive landscape for specialized nutrition products while managing its existing portfolio.
“Antoine de Saint-Affrique said the company has no interest in purchasing Reckitt Benckiser's Mead Johnson infant-formula unit”
The contradiction between the CEO's statement and market reports suggests a strategic tension within Danone's growth planning. While the company is publicly denying a bid to avoid price inflation or regulatory scrutiny, the persistence of these rumors indicates that Mead Johnson remains a primary target for consolidation in the infant-formula industry.
